Abstract
The E2 early protein of human papillomaviruses (HPV) has been found associated with the mitotic spindle therefore being implicated in the partition of the replicated viral DNA to daughter cells. In addition, E2 proteins bind to the upstream regulatory region of the virus and to cellular promoters modulating thereby cellular transcription and differentiation. In many cervical cancers, the E2 reading frame is interrupted upon incorporation of the viral genome into the host DNA. This results in the loss of the E2 mediated transcriptional repression and uncontrolled expression of the viral oncogenes. All these results have been obtained in transfected cells but no information is available on the E2 effects in the context of the entire organism. Transgenic mice were generated expressing the E2 protein of HPV11 under the control of the Ubiquitin C promoter. E2 mRNA is present in all mice tissues analysed and the E2 protein expressed in the skin (the target tissue of HPV11) was shown by Western blotting, albeit at a very low level. Analysis of the transgenic mice shows no major histological changes in the skin or all other tissues investigated. These data indicate that in transgenic mice the human papillomavirus type 11 E2 does not grossly modulate cellular proliferation or differentiation events.
Similar content being viewed by others
References
Arbeit JM, Howley PM, Hanahan D (1996) Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 93:2930–2935
Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962–971
Bellanger S, Demeret C, Goyat S, Thierry F (2001) Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J Virol 75:7244–7251
Bellanger S, Blachon S, Mechali F, Bonne-Andrea C, Thierry F (2005) High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 4:1608–1615
Blachon S, Demeret C (2003) The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Biochimie 85:813–819
Blachon S, Bellanger S, Demeret C, Thierry F (2005) Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. J Biol Chem 280:36088–36098
Bravo IG, Muller M (2005) Codon usage in papillomavirus genes: practical and functional aspects. Papillomavirus Rep 16:63–70
Chao SF, Rocque WJ, Daniel S, Czyzyk LE, Phelps WC, Alexander KA (1999) Subunit affinities and stoichiometries of the human papillomavirus type 11 E1:E2:DNA complex. Biochemistry 38:4586–4594
Corden SA, Sant-Cassia LJ, Easton AJ, Morris AG (1999) The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol 52:275–282
Dao LD, Duffy A, Van Tine BA, Wu SY, Chiang CM, Broker TR, Chow LT (2006) Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J Virol 80:4792–4800
Demeret C, Garcia-Carranca A, Thierry F (2003) Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 22:168–175
Desaintes C, Demeret C (1996) Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 7:339–347
Dong G, Broker TR, Chow LT (1994) Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 68:1115–1127
Eckert RL, Crish JF, Balasubramanian S, Rorke EA (2000) Transgenic animal models of human papillomavirus-dependent disease (Review). Int J Oncol 16(5):853–870
Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S (2003) The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77(9):5253–5265
Hughes AL, Hughes MA (2005) Patterns of nucleotide difference in overlapping and non-overlapping reading frames of papillomavirus genomes. Virus Res 113:81–88
Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B (1998) Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 17:146–153
Leykauf K, Salek M, Bomke J, Frech M, Lehmann WD, Dürst M, Alonso A (2006) Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process. J Cell Sci 119(Pt 17):3634–3642
Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68:362–372
Marcello A, Massimi P, Banks L, Giacca M (2000) Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300. J Virol 74:9090–9098
McCance DJ (2005) Transcriptional regulation by human papillomaviruses. Curr Opin Genet Dev 15:515–519
Nagy A, Gertsenstein M, Vintersten K, Behringer R (2003) Manipulating the mouse embryo. A laboratory manual, 3rd edn. Cold Spring Harbor Press, Cold Spring Harbor, NY
Narechania A, Terai M, Burk RD (2005) Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J Gen Virol 86:1307–1313
Oldak M, Smola H, Aumailley M, Rivero F, Pfister H, Smola-Hess S (2004) The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J Virol 78(19):10738–10746
Parish JL, Kowalczyk A, Chen HT, Roeder GE, Sessions R, Buckle M, Gaston K (2006) E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol 80:4580–4590
Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I (2002) Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143:4084–4095
Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65:1394–1400
Schenkel J, Gaissert H, Protopapa EE, Weiher H, Gissmann L, Alonso A (1999) The human papillomavirus type 11 upstream regulatory region triggers hair-follicle-specific gene expression in transgenic mice. J Invest Dermatol 112:893–898
Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H, Angel P (1996) The human Ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24:1787–1788
Sethi N, Palefsky J (2004) Transcriptional profiling of dysplastic lesions in K14-HPV16 transgenic mice using laser microdissection. FASEB J 18:1243–1245
Stubenrauch F, Colbert AM, Laimins LA (1998) Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J Virol 72:8115–8123
Tan SH, Gloss B, Bernard HU (1992) During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res 20:251–256
Van Tine BA, Dao LD, Wu SY, Sonbuchner TM, Lin BY, Zou N, Chiang CM, Broker TR, Chow LT (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci USA 101(12):4030–4035
White PW, Titolo S, Brault K, Thauvette L, Pelletier A, Welchner E, Bourgon L, Doyon L, Ogilvie WW, Yoakim C, Cordingley MG, Archambault J (2003) Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction. J Biol Chem 278:26765–26772
Winter C, Weiss C, Martin-Villalba A, Zimmermann M, Schenkel J (2002) JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons. Brain Res Mol Brain Res 104:194–202
Yu T, Peng YC, Androphy EJ (2007) Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J Virol 81(4):1736–1745
zur Hausen H, de Villiers EM (1994) Human papillomaviruses. Annu Rev Microbiol 48:427–447
Acknowledgements
We thank Prof. Dr. P. Angel and Dr. Marina Schorpp-Kistner for the kind gift of the Ubiquitin C promoter plasmid and Dr. J. Archambault for the kind gift of antibodies to the HPV11 E2 protein.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leykauf, K., Kabsch, K., Gassler, N. et al. Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern. Transgenic Res 17, 1–8 (2008). https://doi.org/10.1007/s11248-007-9130-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-007-9130-y